Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
Open Access
- 8 October 2010
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 140
Abstract
Lung infection by various organisms is a characteristic feature of cystic fibrosis (CF). CFTR genotype effects acquisition of Pseudomonas aeruginosa (Pa), however the effect on acquisition of other infectious organisms that frequently precede Pa is relatively unknown. Understanding the role of CFTR in the acquisition of organisms first detected in patients may help guide symptomatic and molecular-based treatment for CF.Keywords
This publication has 28 references indexed in Scilit:
- Cystic Fibrosis Pigs Develop Lung Disease and Exhibit Defective Bacterial Eradication at BirthScience Translational Medicine, 2010
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770Proceedings of the National Academy of Sciences of the United States of America, 2009
- Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosaAmerican Journal of Physiology-Cell Physiology, 2009
- Genetic Modifiers Play a Substantial Role in Diabetes Complicating Cystic FibrosisThe Journal of Clinical Endocrinology & Metabolism, 2009
- Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease SeverityPLOS ONE, 2009
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus ReportThe Journal of Pediatrics, 2008
- Heritability of Lung Disease Severity in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilmsProceedings of the National Academy of Sciences, 2006
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensusEuropean Respiratory Journal, 2000